App-Quantinova.ai

Comparison of microfilter-based capture to CellSearch in detection of circulating tumor cells (CTCs) in patients with metastatic castration-resistant prostate cancer (mCRPCa).

Christos Kyriakopoulos - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

N/A

Detection of circulating tumor cells and its correlation with clinical outcome in non-small cell lung cancer.

Milena Tariki - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

Cisplatin

Clinical factors associated with higher detection of circulating tumor cells in patients with pancreatic cancer and their correlation with outcome: A prospective analysis.

Marcello Ferretti Fanelli - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic pancreatic adenocarcinoma

N/A

ClearCell FX: A microfluidic system for label-free circulating tumor cell enrichment.

Andrew Wu - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Predictive value of circulating tumor cells positive for VEGFR expression in patients with advanced colorectal cancer undergoing treatment with FOLFOX plus bevacizumab.

M. Jose Serrano - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

Bevacizumab

Circulating tumor cells (CTCs) in metastatic breast cancer: Ethnicity and disease subtypes.

Tiffany P. Avery - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Association of circulating tumor cells with venous thromboembolism in advanced non-small cell lung cancer.

Robert Lewin Metcalf - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Biomarkers to predict the clinical efficacy of bevacizumab in advanced colorectal cancer: KRAS mutational status of circulating tumor cells.

Marco Danova - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

Bevacizumab

Detection of circulating tumor cells with epithelial-mesenchymal transition phenotype as critical surrogate biomarkers in patients with non-small cell lung cancer.

Shinsaku Togo - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.

Bahriye Aktas - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Circulating tumor cell capture in hepatocellular carcinoma (HCC).

Holly Rochefort - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Detection of lung cancer circulating tumor cells by combining immunomagnetic and size-based separation.

Shadia Ibrahim Jalal - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Probability of detection of circulating tumor cells in colorectal cancer stage III-IV.

Elena Alekseevna Nikipelova - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Correlation between circulating tumor cells (CTC) and plasma cytokines and angiogenic factors (CAF) in early breast cancer patients.

Michal Mego - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Circulating tumor cells in peripheral and pulmonary venous blood and long-term survival in surgically resected non-small cell lung cancer patients.

Yungsong Li - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

DETECT III/IV: Two combined clinical trials based on the phenotype of circulating tumor cells (CTCs).

Susanne Albrecht - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Lapatinib

Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy.

Jordan Madic - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Triple-negative breast cancer

TP53

Gene profiling and circulating tumor cells in patients with locoregional breast cancer.

Renata Kelly Kuniyoshi - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mammary carcinoma

N/A

Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC): A prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomography (PET), and the RECIST criteria.

Brigette Ma - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: A phase II NEOTAX study.

Nuriye zdemir - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic gastric and oesogastric junction (AGC) adenocarcinoma

Fluorouracil

Filters

1671 Abstracts